Elsevier

Immunochemistry

Volume 15, Issues 10–11, November 1978, Pages 839-854
Immunochemistry

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future

https://doi.org/10.1016/0161-5890(78)90117-7Get rights and content

First page preview

First page preview
Click to open first page preview

References (208)

  • AlperC.A. et al.

    Increased susceptibility to infection associated with abnormalities of complement-functions and of the third component of complement (C3)

    New Engl. J. Med.

    (1970)
  • AlperC.A. et al.

    Increased susceptibility to infection associated with abnormalities of complement-functions and of the third component of complement (C3)

    New Engl. J. Med.

    (1970)
  • AlperC.A. et al.

    Homozygous deficiency of C3 in a patient with repeated infections

    Lancet

    (1972)
  • AmmannA.J. et al.

    Polyvalent pneumococcal polysaccharide immunization of patients with sickle cell anemia and patients with splenectomy

    New Engl. J. Med.

    (1977)
  • AndersonP. et al.

    Antibody to polyribophosphate ofHaemophilus influenzae type b

    J. infect. Dis.

    (1977)
  • AndersonP. et al.

    Immunogenicity in weanling rabbits of a polyribophosphate complex fromHaemophilus influenze type b

    J. infect. Dis.

    (1977)
  • ApicellaM.A.

    Identification of a subgroup antigen on theNeisseria meningitidis Group C capsular polysaccharide

    J. infect. Dis.

    (1974)
  • ApicellaM.A. et al.

    Meningococcal Group C subgroup determinant detected by immunofluorescence

  • ArtensteinM.S. et al.

    Prevention of meningococcal disease by Group C polysaccharide vaccine

    New Engl. J. Med.

    (1970)
  • AustrianR.

    Random gleanings from a life with the pneumococcus. Maxwell Finland Lecture

    J. infect. Dis.

    (1975)
  • AustrianR.

    The prevalence of pneumococcal types and the continuing importance of pneumococcal infection

    Am. J. med. Sci.

    (1959)
  • AustrianR.

    Prevention of pneumococcal infection by immunization with capsular polysaccharides ofStreptococcus pneumoniae: current status of polyvalent vaccines

    J. infect. Dis.

    (1977)
  • AustrianR. et al.

    Prevention of pneumococcal pneumonia by vaccination

    Trans. Ass. Am. Physns

    (1976)
  • AustrianR. et al.

    Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia

    Ann. intern. Med.

    (1964)
  • AveryO.T. et al.

    The soluble specific substance of Friedlander's bacillus. Paper II. Chemical and immunological relationships of pneumococcus type II and of a strain of Friedlander's bacillus

    J. exp. Med.

    (1925)
  • BakerC.J.

    Summary of the workshop on perinatal infections due to group BStreptococcus

    J. infect. Dis.

    (1977)
  • BakerC.J. et al.

    Microcapsule of type III strains of Group Bstreptococcus: production and morphology

    Infect. Immun.

    (1976,[object Object])
  • BakerC.J. et al.

    Identification of sialic acid in polysaccharide antigens of Group Bstreptococcus

    Infect. Immun.

    (1976,[object Object])
  • BakerC.J. et al.

    Quantitative determination of antibody to capsular polysaccharide in infection with Type III strains Group BStreptococcus

    J. clin. invest.

    (1977,[object Object])
  • BakerP.J. et al.

    Maturation of regulatory factors influencing magnitude of antibody response to capsular polysaccharide of type IIIStreptococcus pneumoniae

    J. infect. Dis.

    (1977,[object Object])
  • BaltimoreR.S. et al.

    Antigenic specificity of opsonophagocytic antibodies in rabbit antisera to group B streptococci

    J. Immun.

    (1977)
  • BorgonoJ.M. et al.

    Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants

  • BøvreK. et al.

    Neisseria meningitidis infections in northern Norway: an epidemic in 1974–1975 due mainly to Group B organisms

    J. infect. Dis.

    (1977)
  • Branefors-HelanderP. et al.

    Structural studies of the capsular antigen fromHaemophilus influenzaetype b

    Acta chem. scand.

    (1976)
  • CooperN.R. et al.

    Binding and activation of the first component of human complement by the lipid A component of lipopolysaccharides

    J. Immun.

    (1978)
  • DaviesJ.A.

    The response of infants to inoculation with Type I pneumococcus carbohydrate

    J. Immun.

    (1937)
  • DevittL. et al.

    Pneumonia in New Guinea. II. Pneumococcal serotypes and the possible utility of polyvalent vaccines of capsular polysaccharides

    Med. J. Aust.

    (1973)
  • DowlingH.F.

    The rise and fall of pneumonia-control programs

    J. infect. Dis.

    (1973)
  • EganW. et al.

    Structural studies on the sialic acid polymer antigen ofEscherichia coli strain BOS-12

    Biochemistry

    (1977)
  • EganW.M. et al.

    Structural studies of the K 100 capsular polysaccharide antigen ofEscherichia coli

    (1978)
  • EickhoffT.C. et al.

    Neonatal sepsis and other infections due to Group B beta-hemolytic streptococci

    New Engl. J. Med.

    (1964)
  • EkwurzelG.M. et al.

    Studies on the immunizing substances in pneumococci. VIII. Report on field tests to determine the value of a pneumococcus antigen

    Publ. Hlth Rep., Wash.

    (1938)
  • FarrilesJ.S. et al.

    Meningococcal infections in Bolton, 1971–1977

    Lancet

    (1975)
  • FarquharJ.D. et al.

    Clinical and serological evaluation of purified polysaccharide vaccines prepared fromNeisseria meningitidis Group Y

  • FelixA. et al.

    The pathogenic and immunogenic activities ofSalmonella typhi in relation to its antigenic constituents

    J. Hyg., Camb.

    (1951)
  • FeltonL.D.

    The variables in the mouse protection test of antipneumococcus serum

    J. Immun.

    (1930)
  • FeltonL.D.

    Studies on immunizing substances in pneumococci VII. Response in human beings to antigenic pneumococcus polysaccharides, types I and II

    Publ. Hlth Rep., Wash.

    (1938)
  • FeltonL.D. et al.

    Studies on the mechanism of the immunological paralysis induced in mice by pneumococcal polysaccharides

    J. Immun.

    (1955)
  • FinlandM.

    Excursions into epidemiology: selected studies during the past four decades at Boston City Hospital

    J. infect. Dis.

    (1973)
  • FinlandM. et al.

    Changes in occurrence of capsular serotypes ofStreptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974

    J. clin. Microbiol.

    (1977)
  • Cited by (119)

    • New Approaches for Needed Vaccines: Bacteria

      2016, The Vaccine Book: Second Edition
    • Bacterial polysaccharide vaccines: Glycoconjugates and peptide-mimetics

      2009, Microbial Glycobiology: Structures, Relevance and Applications
    • Neoglycoproteins

      2007, Comprehensive Glycoscience: From Chemistry to Systems Biology
    View all citing articles on Scopus
    View full text